Atlas Trials

Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin

Clinical trial NCT02135549 · COMPLETED

Trial details

NCT number
NCT02135549
Sponsor
Boston Therapeutics
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2014-05-01
Primary completion
2014-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.